Shares of Novo Nordisk (NYSE: NVO), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, jumped 5% through 9:55 a.m. ET Monday on a series of positive announcements for its GLP-1 products.

Two of these announcements concern weight loss. One doesn't.

Image source: Getty Images.

Continue reading

Source Fool.com